Concord Wealth Partners’s NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share SMR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-500
Closed -$1.59K 991
2024
Q3
$1.59K Hold
500
﹤0.01% 768
2024
Q2
$1.4K Hold
500
﹤0.01% 698
2024
Q1
$400 Hold
500
﹤0.01% 819
2023
Q4
$155 Hold
500
﹤0.01% 795
2023
Q3
$330 Hold
500
﹤0.01% 998
2023
Q2
$630 Buy
+500
New +$771 ﹤0.01% 977

Other funds holding SMR.WS

Concord Wealth Partners's SMR.WS Position: Q4 2024 in Review

Concord Wealth Partners sold out of NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (SMR.WS) in Q4 2024, closing a stake of 500 shares — an estimated $1.59K sold.

Concord Wealth Partners first reported a position in SMR.WS in Q2 2023 and held it in 6 quarters. The position peaked at $1.59K in Q3 2024. 1 fund tracked by Wall St. Rank holds SMR.WS as of Q4 2024.

  • Concord Wealth Partners reported no remaining NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2024 after selling out during the quarter.
  • Concord Wealth Partners sold 500 NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2024, an estimated $1.59K.
  • Concord Wealth Partners first reported a position in NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q2 2023 and held it in 6 quarters.
  • Concord Wealth Partners's NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $1.59K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2024.

Based on Concord Wealth Partners's 13F filing for Q4 2024, filed 24 Jan 2025.